Organon announces MHRA approval extending duration of use of NEXPLANON® (etonogestrel implant) 68 mg Radiopaque to 5 years
Women’s healthcare company, Organon, announced recently that the UK’s Medical Healthcare products Regulatory Agency (MHRA) has approved an extension of the labelled durati...